Apply your knowledge of chemistry and biology to pharmaceutical practice with our BSc Pharmaceutical Chemistry. Our new Pharmaceutical Chemistry degree has been developed together with our industrial ...

Pharmaceutical industry The latest news relating to the pharmaceuticals industry, including regulation, litigation, business news and relevant industrial and academic research, from the Royal Society ...

Our BSc Pharmaceutical Chemistry with Foundation course offers a broad education in chemistry, and provides you with the skills to succeed in a range of professions. Are you keen to take our BSc ...

A BSc in Pharmaceutical Chemistry encourages students to learn comprehensively about the intricate relationship between chemistry and pharmacy. This knowledge is essential for producing and ...

In RIT’s chemistry BS, you’ll research chemicals to discover, develop, or improve products like paints, pharmaceuticals, cosmetics, electronic components, and more. Prepare for Advanced Degrees: ...

Adding fluorine to drug molecules can be tricky, but is often worthwhile. Rachel Brazil talks to the chemists trying to tame ...

The materials science graduate program seeks to provide solutions for several different fields, including energy, medicine, clothing, and equipment production. Good to Know Chemistry and Biochemistry ...

The course provides a comprehensive introduction to analytical chemistry relevant for chemical quality control of pharmaceutical raw materials and final drug products, and for determination of drugs, ...

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. The synthesis of active pharmaceutical ingredients (APIs) is commonly perceived as ...

They are compatible with many biological targets, such as enzymes and receptors, indicating potential pharmaceutical applications. The bio-active middle molecules synthesized via triple click ...

RBC Capital analyst Luca Issi maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) yesterday and set a price target of $77.00. The company’s shares closed yesterday at ...